Rexford Industrial Realty, Inc. (REXR) Touches $35.45 High on Feb, 13; Fjarde Ap-Fonden Fourth Swedish National Pension Fund Trimmed Merck & Co (MRK) Holding By $2.43 Million

Rexford Industrial Realty, Inc. (NYSE:REXR) Logo

Fjarde Ap-Fonden Fourth Swedish National Pension Fund decreased Merck & Co Inc (MRK) stake by 4.63% reported in 2018Q3 SEC filing. Fjarde Ap-Fonden Fourth Swedish National Pension Fund sold 34,668 shares as Merck & Co Inc (MRK)’s stock rose 11.30%. The Fjarde Ap-Fonden Fourth Swedish National Pension Fund holds 713,907 shares with $50.65M value, down from 748,575 last quarter. Merck & Co Inc now has $205.17B valuation. The stock increased 0.48% or $0.38 during the last trading session, reaching $78.9. About 5.00 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 41.35% since February 13, 2018 and is uptrending. It has outperformed by 41.35% the S&P500. Some Historical MRK News: 06/04/2018 – INCYTE- SAFETY PROFILE OBSERVED IN ECHO-301/KEYNOTE-252 WAS CONSISTENT WITH THAT OBSERVED IN STUDIES OF EPACADOSTAT IN COMBINATION WITH KEYTRUDA; 24/05/2018 – Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck; 18/05/2018 – ASTRAZENECA PLC AZN.L – OFFSET BY EROSION OF CRESTOR SALES; 17/05/2018 – REG-INNATE PHARMA : Preliminary activity observed of the combination of monalizumab and durvalumab in patients with colorectal cancer; 13/04/2018 – Merck Foundation Calls for Action to Break the Infertility Stigma in Africa at FIGO; 27/03/2018 – U.S. Food and Drug Administration (FDA) Accepts Bristol-Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy; 05/03/2018 – Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors; 16/05/2018 – TURNSTONE BIOLOGICS – ENTERED INTO A CLINICAL SUPPLY AGREEMENT WITH F. HOFFMANN-LA ROCHE LTD UNDER WHICH ROCHE WILL PROVIDE ATEZOLIZUMAB (TECENTRIQ); 30/04/2018 – FDA GRANTS PRIORITY REVIEW TO MERCK’S SBLA FOR KEYTRUDA┬«; 22/03/2018 – BerGenBio ASA: BerGenBio to present overview of phase II clinical trial portfolio combining bemcentinib with KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe

The stock of Rexford Industrial Realty, Inc. (NYSE:REXR) reached all time high today, Feb, 13 and still has $37.93 target or 7.00% above today’s $35.45 share price. This indicates more upside for the $3.36B company. This technical setup was reported by Barchart.com. If the $37.93 PT is reached, the company will be worth $235.20M more. The stock increased 1.75% or $0.61 during the last trading session, reaching $35.45. About 349,931 shares traded. Rexford Industrial Realty, Inc. (NYSE:REXR) has risen 5.29% since February 13, 2018 and is uptrending. It has outperformed by 5.29% the S&P500. Some Historical REXR News: 19/04/2018 – REXFORD INDUSTRIAL REALTY- ON APRIL 17, BOARD OF CO EXPANDED BOARD BY ONE SEAT AND ELECTED DIANA J. INGRAM AS A DIRECTOR – SEC FILING; 24/04/2018 – Report: Exploring Fundamental Drivers Behind Enzo Biochem, The Hackett Group, Rexford Industrial Realty, Green Plains, United C; 19/03/2018 – REXFORD INDUSTRIAL REALTY – DEAL FUNDED THROUGH COMBINATION OF CASH ON HAND AND DRAWS ON LINE OF CREDIT; 19/03/2018 – Rexford Industrial Realty: Aquisition Funded Through Cash on Hand and Line of Credit Draw; 24/05/2018 – REXFORD INDUSTRIAL REALTY INC – ACQUISITIONS WERE FUNDED THROUGH A COMBINATION OF CASH ON HAND AND USE OF REXFORD INDUSTRIAL’S EXISTING LINE OF CREDIT; 01/05/2018 – Rexford Industrial Realty Sees FY18 EPS 22c-EPS 25c; 22/04/2018 – DJ Rexford Industrial Realty Inc, Inst Holders, 1Q 2018 (REXR); 01/05/2018 – Rexford Industrial Realty 1Q Rev $48.5M; 10/04/2018 – REXFORD INDUSTRIAL REALTY – ACQUISITIONS WERE FUNDED USING CASH ON HAND, CO’S EXISTING LINE OF CREDIT, RE-INVESTMENT OF DISPOSITION PROCEEDS; 08/04/2018 – REXFORD INDUSTRIAL REALTY INC REXR.N : CAPITAL ONE RAISES TARGET PRICE TO $30

Investors sentiment increased to 1.79 in 2018 Q3. Its up 0.04, from 1.75 in 2018Q2. It increased, as 13 investors sold Rexford Industrial Realty, Inc. shares while 43 reduced holdings. 23 funds opened positions while 77 raised stakes. 89.90 million shares or 3.32% more from 87.01 million shares in 2018Q2 were reported. Aew Limited Partnership has invested 3.11% of its portfolio in Rexford Industrial Realty, Inc. (NYSE:REXR). Natixis Advisors Lp invested 0.06% of its portfolio in Rexford Industrial Realty, Inc. (NYSE:REXR). California Employees Retirement Sys holds 0% of its portfolio in Rexford Industrial Realty, Inc. (NYSE:REXR) for 77,561 shares. Bessemer Gru Inc has invested 0% in Rexford Industrial Realty, Inc. (NYSE:REXR). The Massachusetts-based Geode Capital Mgmt has invested 0.01% in Rexford Industrial Realty, Inc. (NYSE:REXR). Moreover, Tower Research Capital Limited Liability Corporation (Trc) has 0% invested in Rexford Industrial Realty, Inc. (NYSE:REXR) for 802 shares. Bamco Inc Ny stated it has 874 shares. State Of Alaska Department Of Revenue stated it has 0.02% in Rexford Industrial Realty, Inc. (NYSE:REXR). North Star Invest Management stated it has 0.03% of its portfolio in Rexford Industrial Realty, Inc. (NYSE:REXR). Eii owns 0.24% invested in Rexford Industrial Realty, Inc. (NYSE:REXR) for 13,589 shares. Hsbc Public Ltd Com stated it has 10,132 shares or 0% of all its holdings. State Board Of Administration Of Florida Retirement Systems has 0% invested in Rexford Industrial Realty, Inc. (NYSE:REXR). Ubs Asset Mgmt Americas owns 251,730 shares. Schwab Charles Inv Mngmt Inc reported 0.02% in Rexford Industrial Realty, Inc. (NYSE:REXR). Eagle Asset Mgmt reported 0.08% of its portfolio in Rexford Industrial Realty, Inc. (NYSE:REXR).

Since November 16, 2018, it had 1 insider purchase, and 0 selling transactions for $50,466 activity. Khan Adeel bought $50,466 worth of Rexford Industrial Realty, Inc. (NYSE:REXR) on Friday, November 16.

More notable recent Rexford Industrial Realty, Inc. (NYSE:REXR) news were published by: Seekingalpha.com which released: “Rexford Industrial Realty declares $0.185 dividend – Seeking Alpha” on February 12, 2019, also Investorplace.com with their article: “10 Triple-A Stocks to Buy in February – Investorplace.com” published on January 25, 2019, Zacks.com published: “Rexford Industrial (REXR) Q4 FFO and Revenues Beat Estimates – Zacks.com” on February 12, 2019. More interesting news about Rexford Industrial Realty, Inc. (NYSE:REXR) were released by: Streetinsider.com and their article: “Rexford Industrial Realty (REXR) Buys Industrial Property For $18.2 Million – StreetInsider.com” published on December 14, 2018 as well as Seekingalpha.com‘s news article titled: “Rexford Industrial Realty (REXR) Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: October 31, 2018.

Rexford Industrial Realty, Inc. is an equity real estate investment trust. The company has market cap of $3.36 billion. The firm invests in the real estate markets of Southern California, United States. It has a 83.81 P/E ratio. It engages in owning, operating and acquiring industrial properties.

Fjarde Ap-Fonden Fourth Swedish National Pension Fund increased Vistra Energy Corp stake by 58,812 shares to 257,879 valued at $6.42 million in 2018Q3. It also upped Brighthouse Finl Inc stake by 7,600 shares and now owns 38,529 shares. Rollins Inc (NYSE:ROL) was raised too.

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Seekingalpha.com which released: “Merck Q4 2018 Earnings Preview – Seeking Alpha” on January 31, 2019, also Seekingalpha.com with their article: “Merck: Keytruda Contribution Finally Fairly Valued – Seeking Alpha” published on February 04, 2019, Seekingalpha.com published: “Merck’s Keytruda improves survival in certain esophageal cancer patients – Seeking Alpha” on January 15, 2019. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Schaeffersresearch.com and their article: “25 Stocks to Avoid This February – Schaeffers Research” published on January 31, 2019 as well as Bizjournals.com‘s news article titled: “Dash for NASH trips up Gilead, but ‘fatty liver disease’ remains biotech target – San Francisco Business Times” with publication date: February 12, 2019.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart